Últimos testes

EudraCT Number: 2020-004194-51

Sponsor Protocol Number: 020520

Start Date:

Sponsor Name: Medical University of Lodz

Full Title: A prospective, randomized, phase III open-label clinical trial with blinded end-point assessment to evaluate the efficacy and safety of cyclosporine and methotrexate in children and adolescent subj...

Medical condition: Atopic dermatitis

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: PL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2020-005092-13

Sponsor Protocol Number: MO42623

Start Date:

Sponsor Name: F. Hoffmann-La Roche Ltd

Full Title: A MULTICENTER, OPEN-LABEL PHASE IV STUDY TO EVALUATE OVERALL HEALTH, PHYSICAL ACTIVITY, AND JOINT OUTCOMES, IN PARTICIPANTS AGED ≥ 13 AND

Medical condition: Severe or Moderate Hemophilia A

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	100000004850	10053753	Hemophilia A without inhibitors	LLT

Population Age: Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: IE (Prematurely Ended) DE (Ongoing) ES (Ongoing) IT (Ongoing) HU (Ongoing)

Trial results: (No results available)

EudraCT Number: 2010-021802-39

Sponsor Protocol Number: DB2113374

Start Date:

Sponsor Name: GlaxoSmithKline Research & Development Ltd

Full Title: A multicenter trial comparing the efficacy and safety of GSK573719/GW642444 with GSK573719 with tiotropium over 24 weeks in subjects with COPD

Medical condition: Chronic Obstructive Pulmonary Disease (COPD)

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.0	10038738 - Respiratory, thoracic and mediastinal disorders	10010952	COPD	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2018-001931-27

Sponsor Protocol Number: STARS-trial

Start Date:

Sponsor Name: IRCCS Istituto Giannina Gaslini

Full Title: Comparison of STep-up and step-down therapeutic strategies in childhood ARthritiS

Medical condition: Juvenile idiopathic arthritis (JIA) is an umbrella term that encompasses a heterogeneous group of disorders characterised by prolonged synovial inflammation that may cause destructive damage to joi...

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	100000004859	10059177	Juvenile arthritis	LLT

Population Age: Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: IT (Ongoing)

Trial results: (No results available)

EudraCT Number: 2007-000187-25

Sponsor Protocol Number: AC4108123

Start Date:

Sponsor Name: GlaxoSmithKline Research & Development Ltd

Full Title: A randomised, double blind, placebo-controlled, double dummy, 4-way cross-over, dose ascending study to assess the safety, tolerability, pharmacodynamics and pharmacokinetics of single inhaled dose...

Medical condition: Chronic Obstructive Pumonary Disease (COPD)

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10010952	COPD	LLT

Population Age:

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2008-008287-28

Sponsor Protocol Number: ALI-FRA-0030-I

Start Date:

Sponsor Name: University Hospital Erlangen

Full Title: Effect of direct renin-inhibition aliskiren on renal haemodynamic and metabolic parameters in patients with prediabetes

Medical condition: Patients with prediabetes (either impaired glucose tolerance or imparied fasting glucose) and no obvious diabetes mellitus

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.1	10027433 - Metabolism and nutrition disorders	10065542	Prediabetes	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: (No results available)

EudraCT Number: 2019-002636-82

Sponsor Protocol Number: OTL-200-07

Start Date:

Sponsor Name: Orchard Therapeutics (Europe) Limited

Full Title: An open label, non-randomised trial to evaluate the safety and efficacy of a single infusion of OTL-200 in patients with Late Juvenile (LJ) Metachromatic Leukodystrophy (MLD)

Medical condition: Metachromatic Leukodystrophy

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10010331 - Congenital, familial and genetic disorders	10067609	Metachromatic leukodystrophy	PT

Population Age: Children, Under 18

Gender: Male, Female

Trial protocol: IT (Ongoing)

Trial results: (No results available)

EudraCT Number: 2021-005914-33

Sponsor Protocol Number: VX21-445-125

Start Date:

Sponsor Name: Vertex Pharmaceuticals Incorporated

Full Title: A Phase 3 Open-label Study Evaluating the Longterm Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis Subjects With Non-F508del CFTR Genotypes

Medical condition: Cystic Fibrosis

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10010331 - Congenital, familial and genetic disorders	10011762	Cystic fibrosis	PT

Population Age: Children, Adolescents, Under 18, Adults

Gender: Male, Female

Trial protocol: DE (Ongoing) ES (Ongoing) SE (Ongoing) NO (Ongoing) NL (Ongoing) IT (Ongoing) BE (Ongoing) AT (Ongoing) PT (Ongoing) PL (Ongoing) HU (Ongoing) CZ (Ongoing)

Trial results: (No results available)

EudraCT Number: 2007-002420-15

Sponsor Protocol Number: RIC2006

Start Date:

Sponsor Name: Universität Leipzig

Full Title: Phase II-Studie zur Effizienz der vorzeitigen Reduktion von CSA/MMF bei fallendem linienspezifischen Chimärismus nach allogener Stammzelltransplantation nach Konditionierung mit low-dose TBI/Flud...

Medical condition: Effizienz der vorzeitigen Reduktion von CSA/MMF bei fallendem linienspezifischen Chimärismus nach allogener Stammzelltransplantation nach Konditionierung mit low-dose TBI/Fludarabin bei älteren ...

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: (No results available)

EudraCT Number: 2015-001496-48

Sponsor Protocol Number: OTI179

Start Date:

Sponsor Name: BIOCODEX

Full Title: Evaluation de l'efficacité d’une solution de chlorhydrate de lidocaïne 1% et de phénazone 4% en gouttes auriculaires (Otipax®) dans l’otite moyenne aiguë congestive de l’enfant Etude clinique ouv...

Medical condition: Congestive acute otitis media of children

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Infants and toddlers, Children, Under 18

Gender: Male, Female

Trial protocol: FR (Completed)

Trial results: (No results available)

Últimos testes

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas